Innate Pharma (IPHA) Invested Capital (2017 - 2026)
Innate Pharma's Invested Capital was -$23.6 million in the quarter ended Jun 30, 2026, compared with $36.42 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Invested Capital (2017 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Invested Capital at Innate Pharma came in at $981,806, down 97.7% from the prior year.
- Invested Capital shows a five-year compound annual growth rate of -65.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Invested Capital was $43.11 million in the year ended Dec 31, 2024 (-60.4%), $108.96 million in the year ended Dec 31, 2023 (+5.0%), $103.82 million in the year ended Dec 31, 2022 (-40.2%) and $173.53 million in the year ended Dec 31, 2021 (-13.2%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Invested Capital in data going back to the quarter ended Dec 31, 2017.
- The best year-over-year quarter for Invested Capital over five years was the quarter ended Dec 31, 2023 (growth of 0.4%); the worst was the quarter ended Dec 31, 2025 (a decline of 97.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - | -33.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.60 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Jun 30, 2025 | 28.55 Mn |
| Dec 31, 2024 | 32.67 Mn |
| Jun 30, 2024 | 59.69 Mn |
| Dec 31, 2023 | 92.38 Mn |
| Jun 30, 2023 | 103.18 Mn |
| Dec 31, 2022 | 102.17 Mn |
| Jun 30, 2022 | 135.43 Mn |
| Dec 31, 2021 | 137.70 Mn |
| Jun 30, 2021 | 182.90 Mn |
| Dec 31, 2020 | 213.52 Mn |
| Jun 30, 2020 | 252.84 Mn |
| Dec 31, 2019 | 262.30 Mn |
| Dec 31, 2018 | 195.00 Mn |
| Dec 31, 2017 | 109.25 Mn |
API Access
Innate Pharma Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();